Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: November 26, 2022

Ceftazidime - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What are the generic drug sources for ceftazidime and what is the scope of patent protection?

Ceftazidime is the generic ingredient in ten branded drugs marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, Glaxosmithkline, Pai Holdings Pharm, Hospira, Lilly, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime. Four suppliers are listed for this compound.

Summary for ceftazidime
Recent Clinical Trials for ceftazidime

Identify potential brand extensions & 505(b)(2) entrants

Arrevus Inc.Phase 2
King Faisal Specialist Hospital & Research CenterPhase 3
Dr. Promise Tamunoipiriala JajaPhase 2

See all ceftazidime clinical trials

Pharmacology for ceftazidime
Medical Subject Heading (MeSH) Categories for ceftazidime

US Patents and Regulatory Information for ceftazidime

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pai Holdings Pharm FORTAZ ceftazidime INJECTABLE;INJECTION 050578-003 Jul 19, 1985 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065481-003 May 28, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira TAZICEF ceftazidime INJECTABLE;INJECTION 062662-002 Mar 6, 1986 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.